GHP Q2 2023

Welcome to the Q2 edition of Global Health & Pharma Magazine 2023, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape. Q2 2023 As we find ourselves half way through the year already, we have so many exciting developments to share with you. In this issue, we’re pleased to be featuring an array of innovative companies delivering cutting-edge solutions for healthcare providers, whether practice management software, an orthopaedic medical device, or healthcare informatics digital platform. Each is designed to enable the utmost efficiency and an excellent experience for patients. Then there are those outstanding companies providing services and products for individuals who need them, such as online mindfulness training, home care, dental treatments, earwax removal, skincare, as well as a nutritional drink supplement, all developed to contribute to the best quality of life possible. And on our front cover, we’re delighted to be featuring Dynamic DNA Laboratories, who we’ve named as Best Supplier of At-Home DNA Testing Kits. Operating within its hi-tech genetics, microbiology, cellular, and microscopy laboratory, the Dynamic DNA team specialise in advanced DNA testing and strive to promote positive change by helping people better understand themselves. All it takes is a cheek swab and the company can help you learn more about your ancestry and health by analysing your genetic code. We hope you find this issue to be informative and insightful and wish you a prosperous quarter ahead. In the meantime, we looking forward to welcoming you back again for Q3 issue. Rebecca Scotland, Editor Website: AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.